Published • loading... • Updated
A year after distressed buyout, what’s become of Bluebird Bio?
Summary by STAT
2 Articles
2 Articles
A year after distressed buyout, what’s become of Somerville’s Bluebird Bio? - The Boston Globe
David Meek bought the company last year for the pharma industry equivalent of loose change. The company was on the brink of bankruptcy. In 12 months, he says, it’s been transformed.
·Boston, United States
Read Full Article
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources2
Leaning Left1Leaning Right0Center1Last UpdatedBias Distribution50% Left, 50% Center
Bias Distribution
- 50% of the sources lean Left, 50% of the sources are Center
50% Center
L 50%
C 50%
Factuality
To view factuality data please Upgrade to Premium
